u 37883a has been researched along with bay-k-8644 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anwar, M; Banister, RE; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
Ito, Y; Naito, S; Teramoto, N; Tomoda, T; Yunoki, T | 1 |
2 other study(ies) available for u 37883a and bay-k-8644
Article | Year |
---|---|
Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil | 1998 |
Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Adenosine Triphosphate; Analysis of Variance; Animals; Barium; Calcium Channel Agonists; Cromakalim; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Membrane Potentials; Morpholines; Muscle Cells; Nitroprusside; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Swine; Time Factors; Urethra; Vasodilator Agents | 2005 |